bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · IEX Real-Time Price · USD
1.220
+0.020 (1.67%)
At close: Jul 26, 2024, 4:00 PM
1.230
+0.010 (0.82%)
After-hours: Jul 26, 2024, 6:52 PM EDT
bluebird bio Market Cap
bluebird bio has a market cap or net worth of $235.15 million as of July 26, 2024. Its market cap has decreased by -39.46% in one year.
Market Cap
235.15M
Enterprise Value
364.56M
1-Year Change
-39.46%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since June 19, 2013, bluebird bio's market cap has decreased from $588.50M to $235.15M, a decrease of -60.04%. That is a compound annual growth rate of -7.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 131.20M | -13.06% |
| Dec 29, 2023 | 150.90M | -73.70% |
| Dec 30, 2022 | 573.70M | -18.09% |
| Dec 31, 2021 | 700.40M | -75.61% |
| Dec 31, 2020 | 2.87B | -40.85% |
| Dec 31, 2019 | 4.86B | -10.51% |
| Dec 31, 2018 | 5.43B | -33.53% |
| Dec 29, 2017 | 8.16B | 254.64% |
| Dec 30, 2016 | 2.30B | -2.28% |
| Dec 31, 2015 | 2.36B | -10.90% |
| Dec 31, 2014 | 2.64B | 429.89% |
| Dec 31, 2013 | 498.90M | -15.23% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 23andMe Holding Co. | 227.80M |
| Butterfly Network | 227.56M |
| ESSA Pharma | 226.69M |
| 2seventy bio | 225.16M |
| Pyxis Oncology | 222.01M |
| Inogen | 221.62M |
| Cybin | 216.13M |
| P3 Health Partners | 210.91M |